Latest News
New Drugs and Therapeutics Update: Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D)
Teplizumab Approval Expanded to Children >1 Year with Stage 2 Type 1 Diabetes (T1D) Prepared on behalf of PES Drugs and Therapeutics Committee by Pranav Gupta,…
Featured Resources
Mission Alliance Partners
These organizations share similar missions and values to PES. Learn more about our Mission Alliance Partners, and find out how you can become one.
PLATINUM Mission Alliance Partners
GOLD Mission Alliance Partners

